Thursday 2th September, 2010 | 5:58 pm
Home
|
Sitemap
|
Contact us
Stock Quote
|
Press Releases
|
Financial Reports
|
Electronic IR Package
|
Site Search:
Stock Quote
Press releases
Financial Reports
Analysts
Webcast
Q4 Announcement
Home
GHRH Phase II Final Results
Fentanyl TAIFUN Phase IIb extension arm results
Q1 Earnings Announcement
Q2 Earnings Announcement
Akela Pharma, name change and corporate update
Media
Electronic IR Package
Contact
Financial Reports
Annual Information Forms
Year Ended December 31, 2007
Year Ended December 31, 2008
Year Ended December 31, 2009
MDA - 2007
Q1
Q2
Q3
Q4
MDA - 2008
Q1
Q2
Q3
Q4
MDA - 2009
Q1
Q2
Q3
Q4
MDA - 2010
Q1
Q2
CFS
Year ended December 31st, 2006 and 2005
Three-month periods ended March 31st, 2007 and 2006
Three-month periods ended June 30, 2007 and 2006
Three-month periods ended September 30, 2007 and 2006
Years ended December, 2007 and 2006
Three-month periods ended March 31, 2008 and 2007
Three-month periods ended June 30, 2008 and 2007
Three-month periods ended September 30, 2008 and 2007
Years ended December 31, 2008 and 2007
Three-month periods ended March 31
, 2009 and 2008
Three-month periods ended
June 30, 2009 and 2008
Three-month periods ended
September 30, 2009 and 2008
Years ended December 31, 2009 and 2008
Three-month periods ended March 31
, 2010 and 2009
Three-month periods ended
June 30, 2010 and 2009
Home
::
Our Company
::
Investor Relations
::
Products and Technologies
::
Business Units
::
Contact us
::
Site map
::
FAQ
Copyright 2007 © Akela Pharma
